TrialBMC medicine2025

Hepatic artery infusion of FOLFOX chemotherapy plus camrelizumab combined with sorafenib for advanced hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (Double-IA-001): a phase II trial.

Lujun Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.